US EditionNeurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences CEO Andy Doraiswamy will discuss the company’s growth, commercial momentum, and the Dayspring treatment for chronic edema at the J.P. Morgan Healthcare Conference.
- Neurocrine Biosciences will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco at 8:15 A.M. Pacific Time.
- CEO Andy Doraiswamy will use the presentation to highlight Neurocrine Biosciences, Inc.'s growth, commercial momentum, and progress on company pipeline and clinical research.
- A live audio webcast will stream on Neurocrine Biosciences' Investors website at www.neurocrine.com, with a replay posted about one hour after and archived for approximately one month.
- Dayspring, a non‑pneumatic compression treatment for chronic edema, the company said, targets more than 35 million Americans with venous and lymphatic diseases.
- The press release includes a Safe Harbor caveat and contains forward‑looking statements within securities laws, cautioning readers and investors not to place undue reliance as Neurocrine Biosciences assumes no obligation to update them.
56 Articles
56 Articles
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th…
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January…
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 6, 2026 /PRNewswire/ -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced that Jin-Seok Seo, Chief Executive Officer and Hyuk-Jae Lee, Senior Executive Vice President at Celltrion, will present at the 44th Annual J.P.…
Montana Standard
Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
TOKYO, Jan. 6, 2026 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, Calif. As…
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium